Table 7.
Motor and activity of daily living outcomes of patients in previous studies of bilateral subthalamic nucleus stimulation in PD.
| Study | % of Change of UPDRS III “off” | % of Change of UPDRS III “on” | % of Change of UPDRS II “off” |
|---|---|---|---|
| Limousin et al. [58] | −60% | −10% | −60% |
| Ostergaard et al. [59] | −64.3% | * | −66.3% |
| Simuni et al. [62] | −47.1% | −2% | * |
| Thobois et al. [64] | −55% | * | −52.8% |
| Vesper et al. [60] | −48% | −39% | −38% |
| Vingerhoets et al. [63] | −45% | * | −37% |
| Volkmann et al. [65] | −60.3% | * | −55.9% |
| Herzog et al. [61] | −57.2% | −35% | −43.6% |
| Krause et al. [66] | −38.3% | * | −17% |
| Fraix et al. [67] | −66.5 | −16% | * |
| Kleiner-Fisman et al. [68] | −39% | * | −26% |
| Krack et al. [69] | −54% | +47.6 | −49% |
| Romito et al. [70] | −51.6% | * | −68.5% |
| Visser-Vandewalle et al. [71] | −42.8% | −22.6% | −59.4% |
| Rodrguez-Oroz et al. [72] | −62.0% | * | −62.0% |
| Rodrguez-Oroz et al. [73] | −50% | −12.3% | −43.1% |
| Wider et al. [74] | −25.5% | +26% | * |
| Gervais-Bernard et al. [75] | −55% | −11.2% | −38.1% |
| Castrioto et al. [26] | −25.3% | +44.7 | −23% |
| Weaver et al. [76] | −30.1% | +11.1% | −6.25% |
| Li et al. [77] | −60.3% | * | −54.2% |
| Tabbal et al. [78] | −47% | * | * |
| This study | −49.3% | −36.5% | −73.8% |
%: percentage, *: no available data, UPDRS: Unified Parkinson’s Disease Rating Scale, PD: Parkinson’s disease.